51 related articles for article (PubMed ID: 2773695)
1. [Expectations of the patient and attitudes toward treatment as predictive factors in the clinical course of affective disorders].
Vaz-Leal FJ; Salcedo-Salcedo MS; Silvestre-García M
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1989; 17(3):215-22. PubMed ID: 2773695
[TBL] [Abstract][Full Text] [Related]
2. Great expectations: factors influencing patient expectations and doctors recommendations at a Mood Disorders Unit.
Wilhelm K; Wedgwood L; Malhi G; Mitchell P; Austin MP; Kotze B; Niven H; Parker G
J Affect Disord; 2005 Oct; 88(2):187-92. PubMed ID: 16111765
[TBL] [Abstract][Full Text] [Related]
3. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
Mouchabac S; Ferreri M; Cabanac F; Bitton M
Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
[TBL] [Abstract][Full Text] [Related]
4. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
[TBL] [Abstract][Full Text] [Related]
5. Improvement of cognitive functioning in mood disorder patients with depressive symptomatic recovery during treatment: an exploratory analysis.
Mandelli L; Serretti A; Colombo C; Florita M; Santoro A; Rossini D; Zanardi R; Smeraldi E
Psychiatry Clin Neurosci; 2006 Oct; 60(5):598-604. PubMed ID: 16958944
[TBL] [Abstract][Full Text] [Related]
6. Current concepts in clinical therapeutics: major affective disorders, Part 1.
Bryant SG; Brown CS
Clin Pharm; 1986 Apr; 5(4):304-18. PubMed ID: 3519059
[TBL] [Abstract][Full Text] [Related]
7. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
[TBL] [Abstract][Full Text] [Related]
8. [Mode of onset and two years outcome of a broad spectrum of affective disorders].
Hirai T; Furukawa T; Kitamura T; Takahashi K
Seishin Shinkeigaku Zasshi; 1999; 101(6):495-508. PubMed ID: 10475047
[TBL] [Abstract][Full Text] [Related]
9. Compliance with antidepressants in a primary care setting, 2: the influence of gender and type of impairment.
Demyttenaere K; Enzlin P; Dewé W; Boulanger B; De Bie J; De Troyer W; Mesters P
J Clin Psychiatry; 2001; 62 Suppl 22():34-7. PubMed ID: 11599646
[TBL] [Abstract][Full Text] [Related]
10. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
11. Interaction between SERTPR and stressful life events on response to antidepressant treatment.
Mandelli L; Marino E; Pirovano A; Calati R; Zanardi R; Colombo C; Serretti A
Eur Neuropsychopharmacol; 2009 Jan; 19(1):64-7. PubMed ID: 18815011
[TBL] [Abstract][Full Text] [Related]
12. [Antidepressants consumption in the global population in France].
Olié JP; Elomari F; Spadone C; Lépine JP
Encephale; 2002; 28(5 Pt 1):411-7. PubMed ID: 12386542
[TBL] [Abstract][Full Text] [Related]
13. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
[TBL] [Abstract][Full Text] [Related]
14. No predictors of antidepressant patient response to milnacipran were obtained using the three-factor structures of the Montgomery and Asberg Depression Rating Scale in Japanese patients with major depressive disorders.
Higuchi H; Sato K; Yoshida K; Takahashi H; Kamata M; Otani K; Yamaguchi N
Psychiatry Clin Neurosci; 2008 Apr; 62(2):197-202. PubMed ID: 18412843
[TBL] [Abstract][Full Text] [Related]
15. Bipolar mood disorders among Polish psychiatric outpatients treated for major depression.
Rybakowski JK; Suwalska A; Lojko D; Rymaszewska J; Kiejna A
J Affect Disord; 2005 Feb; 84(2-3):141-7. PubMed ID: 15708411
[TBL] [Abstract][Full Text] [Related]
16. Effects of sertraline on mood and immune status in patients with major depression and HIV illness: an open trial.
Rabkin JG; Wagner G; Rabkin R
J Clin Psychiatry; 1994 Oct; 55(10):433-9. PubMed ID: 7961520
[TBL] [Abstract][Full Text] [Related]
17. Treatment emergent affective switch: a controlled study.
Tamada RS; Issler CK; Amaral JA; Sachs GS; Lafer B
Bipolar Disord; 2004 Aug; 6(4):333-7. PubMed ID: 15225153
[TBL] [Abstract][Full Text] [Related]
18. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline.
Brady KT; Clary CM
Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296
[TBL] [Abstract][Full Text] [Related]
19. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
[TBL] [Abstract][Full Text] [Related]
20. The longitudinal polymorphism of bipolar I disorders and its theoretical implications.
Marneros A; Roettig S; Roettig D; Tscharntke A; Brieger P
J Affect Disord; 2008 Apr; 107(1-3):117-26. PubMed ID: 17884177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
